DMII
Drugs Made In America Acquisition II Corp
3월 13일 4:00 PM ET (한국 3/14 05:00)
$9.95
+0.00 +0.00%
🌙 3월 13일 4:00 PM ET (한국 3/14 05:00)
$9.95
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | 21.51% | Shs Outstand | 0.07B | Perf Week | 0.1% |
| Market Cap | 0.65B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.05B | Perf Month | -0.4% |
| Enterprise Value | 0.65B | PEG | - | EPS next Q | - | Inst Own | 53.04% | Short Float | 0.15% | Perf Quarter | 0.71% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.63 | Perf Half Y | - |
| Sales | - | P/B | 1.35 | EPS next 5Y | - | ROA | - | Short Interest | 0.08M | Perf YTD | 0.51% |
| Book/sh | 7.36 | P/C | 2038.97 | EPS past 3/5Y | - | ROE | - | 52W High | -0.6% ($10.01) | Perf Year | - |
| Cash/sh | 0 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 0.91% ($9.86) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 0.1% 0.1% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.02 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.32 | EPS Q/Q | - | Profit Margin | - | RSI (14) | 44.1 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.32 | Sales Q/Q | - | SMA20 | -0.26% ($9.98) | Beta | - | Target Price | - |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | -0.06% ($9.96) | Rel Volume | 0.03 | Prev Close | $9.95 |
| Employees | - | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | 0.12% ($9.94) | Avg Volume(3M) | 0.12M | Price | $9.95 |
| IPO | 2025/12/3 | Option/Short | No/Yes | Trades | 20 | Volume | 3,443 | Change | - |
뉴스 로딩 중...